Key dates30 SEP 2026Early Bird Registration12 OCT 2026Mid Term Registration
—days to opening
3rd Edition · Singapore 2027· #CIOC2027
International Cancer & Immuno-Oncology Conference 2027
Transforming cancer care: innovations, integrations, & impact.
A three-day hybrid congress convening oncologists, immunologists, clinical researchers and policymakers to translate breakthroughs at the bench into outcomes at the bedside.
Dates
15-17 March 20272027 · 3 days
Venue
SingaporeVillage Hotel Changi
Format
Hybrid EventIn-person & online
CPD
Accredited
Hybrid Event
Venue
Village Hotel Changi, Singapore
Edition
3rd edition of the series
Tracks
26 scientific sessions
Speakers
21 confirmed
Countries
13 represented
§ 01 About
About CIOC 2027
A three-day hybrid congress convening oncologists, immunologists, clinical researchers and policymakers to translate breakthroughs at the bench into outcomes at the bedside.
We are delighted to invite you to attend the 3rd Edition of International Cancer & Immuno-Oncology Conference (CIOC 2027), scheduled to be held from March 15–17, 2027, in Singapore and virtually. The conference will revolve around the theme “Innovations in Cancer Research and Treatment for Better Patient Outcomes,” highlighting the latest advancements and collaborative efforts in the global fight against cancer.
This Hybrid Conference will gather a diverse group of participants, including oncologists, cancer researchers, clinicians, healthcare professionals, scientists, industry experts, and students from across the globe. It serves as a multidisciplinary platform encouraging collaboration among professionals from universities, hospitals, research institutions, and healthcare industries.
CIOC 2027 will cover a wide range of topics closely related to oncology and immuno-oncology, including Cancer Biology, Cancer Genetics, Palliative Care, Precision Medicine, Immunotherapy, Radiation Oncology, Targeted Therapies, Cancer Prevention, Pediatric Oncology, and Translational Research. It will also emphasize emerging trends such as genomics, molecular diagnostics, artificial intelligence in oncology, and novel therapeutic approaches designed to enhance patient care and outcomes.
The conference will feature an extensive scientific program, including keynote speeches, plenary sessions, oral and poster presentations, workshops, symposiums, and panel discussions. These sessions will provide attendees with opportunities to present their research, gain insights from leading experts, and engage in meaningful discussions on recent developments and future directions in cancer science.
We look forward to welcoming you to Singapore and virtually for this inspiring and impactful event and to fostering meaningful collaborations in the fight against cancer.
29+
Countries represented to date
98+
Speakers to date
26
Scientific sessions
3
Days, hybrid format
§ 02 Audience
Who should attend.
/ 01
Medical & Clinical Oncologists
Translate emerging trial evidence into treatment decisions.
/ 02
Surgical & Radiation Oncologists
Compare multimodal approaches and organ-specific techniques.
/ 03
Cancer Researchers & Tumour Biologists
Present findings and explore mechanisms driving disease.
/ 04
Immunologists & Cell Therapy Scientists
Advance immuno-oncology, checkpoint and cell-based therapies.
/ 05
Geneticists & Molecular Profilers
Share work in cancer genetics, genomics and biomarkers.
/ 06
Pathologists & Diagnostic Specialists
Explore detection, imaging and early-diagnosis methods.
/ 07
Clinical Trial Investigators
Discuss trial design, endpoints and translational pathways.
/ 08
Paediatric & AYA Oncology Specialists
Address the distinct needs of younger patients.
§ 03 Program · Tracks
Scientific sessions.
/ 01
Early Detection, Screening & Prevention
Early detection and prevention remain central to reducing cancer incidence, morbidity, and mortality. This session expl…
Track 01View session/ 02Cancer Epidemiology, Population Health, Access & Policy
This session addresses the distribution, determinants, and burden of cancer across populations and examines how healthc…
Track 02View session/ 03Cancer Pathology, Molecular Diagnostics & Biomarkers
Accurate diagnosis and molecular characterization are fundamental to modern cancer management. This session explores de…
Track 03View session/ 04Cancer Genetics, Genomics & Precision Oncology
Advances in genetics and genomics have transformed the understanding and treatment of cancer. This session focuses on h…
Track 04View session/ 05Cancer Biology & Tumor Microenvironment
Understanding the biological mechanisms that drive cancer initiation, progression, metastasis, and treatment resistance…
Track 05View session/ 06Breast Oncology
Breast oncology encompasses the prevention, diagnosis, molecular characterization, and multidisciplinary treatment of b…
Track 06View session/ 07Lung & Thoracic Oncology
Lung and thoracic malignancies remain major areas of cancer research and clinical innovation. This session covers advan…
Track 07View session/ 08Gastrointestinal Cancer
Gastrointestinal oncology covers a diverse group of malignancies affecting the digestive system and associated organs.…
Track 08View session/ 09Genitourinary Cancers
Genitourinary oncology encompasses cancers of the urinary system and male reproductive organs and continues to benefit…
Track 09View sessionSingapore · 15-17 March 2027
Until the opening plenary.
—
Days
—
Hours
—
Minutes
—
Seconds
Opens March 15–17, 2027
Village Hotel Changi, Singapore
Village Hotel Changi, Singapore
§ 04 Important Dates
Key dates & deadlines.
28 Sep 2026First Round SubmissionClosed
30 Sep 2026Early Bird RegistrationNext
12 Oct 2026Mid Term RegistrationUpcoming
13 Oct 2026Second Round SubmissionUpcoming
1 Mar 2027Final Round SubmissionUpcoming
15 Mar 2027On Spot RegistrationUpcoming
§ 05 Scientific Committee
Committee members.
Jianhua Luo
University of Pittsburgh School of Medicine, United States
Atif A Ahmed
Seattle Children’s Hospital, United States
Rajvir Dahiya
University of California San Francisco, United States
Manmohan Agrawal
Pushpadi Hospital, India
Yan Leyfman
NYP- Meyer Cancer Center, United States
Michael Thompson
University of Toronto, Canada
Pietro Salvatori
Formerly, Humanitas San Pio X Hospital, Italy
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil§ 06 Featured Speakers
2027 speakers.
Jianhua Luo
University of Pittsburgh School of Medicine, United StatesAtif A Ahmed
Seattle Children’s Hospital, United StatesRajvir Dahiya
University of California San Francisco, United States
Thomas Jay Webster
Brown University, United StatesYan Leyfman
NYP- Meyer Cancer Center, United StatesMichael Thompson
University of Toronto, CanadaPietro Salvatori
Formerly, Humanitas San Pio X Hospital, ItalyPaulo Cesar De Morais
Catholic University of Brasilia, Brazil
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationManmohan Agrawal
Pushpadi Hospital, India
Ahora Chehri
Johann Wolfgang Goethe Universität Frankfurt am, Germany
Eleni Petsalaki
University of Crete, Greece§ 07 Accreditation
Continuing professional development.
CIOC 2027 is CPD accredited. Full accreditation details, including how credits are earned, are published on the accreditation page.
CPD Accredited
§ 09 Past Editions
Previous editions.
§ 10 Programme
Conference schedule.
Day 01
Keynote Presentation (In-Person)Long-read sequencing reveals dynamic features of human malignanciesJianhua LuoUniversity of Pittsburgh School of Medicine, United StatesKeynote Presentation (In-Person)Nanomedicine in over 45,000 patients and no cancerThomas Jay WebsterBrown University, United StatesKeynote Presentation (In-Person)Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers and consumers to realize the potential of genomics-informed care to secure human biosafetySergey SuchkovN.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationOral Presentation (In-Person)Personalized and precision medicine as a unique avenue to have the healthcare model renewed to secure national biosafety: To get cancer treated or cured?Sergey SuchkovN.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationOral Presentation (In-Person)Tumor resectability and pathologic response after neoadjuvant long-course chemoradiotherapy for locally advanced rectal cancer in a resource-limited settingSamrawit S HalakeKampala International University, UgandaOral Presentation (In-Person)Horizon Spectra: A comprehensive cancer genomics tertiary platform for ultra-rapid analysisMohammed UddinGenomeArc Inc, CanadaDay 02
Keynote Presentation (Virtual)Precision oncology, genetic testing and gene therapyRajvir DahiyaUniversity of California San Francisco, United StatesKeynote Presentation (Virtual)Graphene quantum dots: A new frontier for photodynamic therapyPaulo Cesar De MoraisCatholic University of Brasilia, BrazilOral Presentation (Virtual)A novel mechanism of mitotic spindle formation in cancer cellsEleni PetsalakiUniversity of Crete, GreeceOral Presentation (Virtual)Human papillomavirus prevalence and genotype distribution among cervical cancer susceptible women of North Indian ethnicity in Gardasil vaccination era: Public health impactSaumya PandeyIndira IVF Hospital, IndiaOral Presentation (Virtual)Genome-wide identification of SOX7 downstream targets and pathways in multiple myeloma through ChIP-Seq and RNA-SeqCan KüçükDokuz Eylul University, TurkeyPoster Presentation (Virtual)AI-guided optimization and structure-based virtual screening identify novel dual-state KRAS G12D inhibitor candidatesMohamed S KhattabSuez Canal University, EgyptDay 03
Keynote Presentation (Virtual)Nanoparticle-based chemiluminescent detection of an ovarian cancer biomarker – A clinically-relevant pilot studyMichael ThompsonUniversity of Toronto, CanadaKeynote Presentation (Virtual)Evolving concepts of breast cancer management and recent trendsManmohan AgrawalPushpadi Hospital, IndiaOral Presentation (Virtual)Investigating the role of mesenchymal stem cell exosomes programmed by the breast cancer microenvironment in the rearrangement of inflammatory pathways, phenotypic changes, and interaction with immune cells in a multicellular in vitro modelAhora ChehriJohann Wolfgang Goethe Universität Frankfurt am, GermanyOral Presentation (Virtual)The mathematical interpretation of breast cancer drugsRatan Kumar SarkarIndependent Researcher, India§ 11 Past Conference Reviews
Hear from delegates.
§ 13 Testimonials
What past delegates say.
Thank you for a global scientifically stimulating enriching dynamic collaborative global platform to intellectually serve as expert moderator-chair and speaker (oral presentation) at this prestigious meeting.
Abdel Ghany F. ShoairDamietta University · Egypt
"I was glad for everything regarding my part of the conference including the interest in my presentation although it was the last one in the conference. However, some of the presentations were of poor quality. For example, all slides of one of the presentations were full of long sentences with no figures at all. At the beginning or end of certain presentations, there was not a moderator available to answer the presenters' questions. Some presenters were not able to upload and proceed with their presentations. As a suggestion, moderators may guide the presenters better for ppt uploads as zoom may be sometimes confusing to handle. The conference participants may be more motivated during their presentations if one or a couple of presentations are awarded with a best presentation award."
Can KüçükDokuz Eylul University · Turkey
"I'm very honored to have participated in the conference ""Cancer Research 2025”. During this conference, I learned a great deal about various aspects of tumor treatment through communicating with all of the participants, and it also broadened my horizons. Thank you for giving me this opportunity."
Jian LiShanghai Jiaotong University · China
Why attend
Why attend the International Cancer & Immuno-Oncology Conference.
Connect, learn, present, and collaborate with the global cancer research and oncology community.
Present your work to a global oncology community
Share research through oral and poster sessions and receive feedback from international peers.
Translate new evidence into treatment decisions
Engage with trial results, treatment advances and organ-specific developments across tumour types.
Advance immuno-oncology and cell-based therapy
Explore checkpoint inhibition, adoptive cell therapy, cancer vaccines and tumour immunology.
Connect genomic insight to clinical practice
Discuss cancer genetics, genomics, biomarkers and molecular profiling in diagnosis and therapy selection.
Compare multimodal treatment approaches
Examine surgical technique, radiotherapy advances and combined-modality strategies.
Address the needs of younger patients
Explore paediatric tumour biology, treatment tolerance, late effects and long-term follow-up.
Improve quality of life across the pathway
Discuss symptom control, supportive oncology, survivorship and end-of-life care.
Strengthen patient care and coordination
Learn from practice-based research across the treatment and survivorship pathway.
Apply computational methods to oncology
Discover developments in artificial intelligence, imaging analysis, real-world data and computational oncology.
Develop skills and professional connections
Present emerging work, receive expert feedback and build international academic networks.
Strengthen research visibility and collaboration
Support faculty, students and clinical teams in presenting their work and developing partnerships.
Connect cancer evidence with policy and practice
Engage with research on prevention, screening, epidemiology, access and care standards.
Connect with oncology decision-makers
Showcase technologies, therapeutics and services to researchers, clinicians and institutions.
Exchange knowledge across health systems
Compare treatment protocols, research priorities and care models with professionals from different countries.
Learn without submitting an abstract
Attend sessions, interact with speakers and stay updated on current cancer research and practice.
Venue
Village Hotel Changi, Singapore.
A secluded, purpose-equipped conference venue close to Singapore Changi Airport, with a dedicated plenary hall and parallel-session rooms for the full programme.
- Address
- 1 Netheravon Road, Singapore 508502
- Nearest airport
- Singapore Changi Airport
- Airport transfer
- Approximately 25 minutes by taxi
- Public transport
- Accessible by public bus; final MRT connection requires bus or taxi
Get in Touch
Reach the conference secretariat.
Questions about registration, abstracts, or partnership? Send us a message and our team will reply within one working day.
15-17 March 2027 · Village Hotel ChangiJoin cancer researchers and clinicians from around the world
Join cancer researchers and clinicians from around the world
in Singapore.
Early-bird registration closes 30 Sep 2026. Abstract submissions (2nd round) close 13 Oct 2026.